Literature DB >> 3109778

Stability of free apolipoprotein A-1 concentration in serum, and its measurement in normal and hyperlipidemic subjects.

R H Neary, E Gowland.   

Abstract

Free apolipoprotein A-1 (free A-1) is a low-molecular-mass complex of protein and lipid containing apolipoprotein A-1 (apo A-1). Using crossed immunoelectrophoresis, we separated free A-1 from the apo A-1 in high-density lipoproteins (HDL) and quantified free A-1 by comparison with a reference serum (containing 1.45 g of apo A-1 per liter) diluted in 9 mol/L urea solution. This latter treatment yields apo A-1 containing protein-lipid complexes of the same size and electrophoretic mobility as free A-1. Within-day precision (CV), determined by replicate analysis of two samples with mean free A-1 concentrations of 48 and 138 mg/L, was 9.1 and 7.2%, respectively. We also showed that the concentration of free A-1 is not stable in serum or plasma either at 4 degrees C or when frozen. The mean concentration of free A-1 in 28 fasted, healthy subjects was 75.3 (SD 13.6) mg/L. The postprandial increase was not statistically significant. The percentage of total apo A-1 in the free form in serum ranged from 3.5% to 8.1%, less than the 10% to 30% reported by others who used radial immunodiffusion to measure free A-1. Because radial immunodiffusion does not separate free A-1 from HDL, we believe that that technique overestimates free A-1. We also used crossed immunoelectrophoresis to measure free A-1 in 76 hyperlipidemic patients. Those with Fredrickson types III and V had significantly increased concentrations of free A-1 (P less than .0001). Correlations between free A-1 and cholesterol and triglycerides in serum were significant (P less than .005 and P less than .001, respectively). Possible roles for free A-1 in lipid metabolism are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109778

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Alpha-helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux.

Authors:  H Hara; H Hara; A Komaba; S Yokoyama
Journal:  Lipids       Date:  1992-04       Impact factor: 1.880

2.  Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.

Authors:  M A Clay; D A Cehic; D H Pyle; K A Rye; P J Barter
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

3.  Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol.

Authors:  B S Horowitz; I J Goldberg; J Merab; T M Vanni; R Ramakrishnan; H N Ginsberg
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

4.  Lipid-free apolipoprotein A-I exerts an antioxidative role against cell-free hemoglobin.

Authors:  Ruijuan Du; Imelda Winarsih; Bow Ho; Jeak Ling Ding
Journal:  Am J Clin Exp Immunol       Date:  2012-05-30

5.  Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis.

Authors:  S M Hammad; S Stefansson; W O Twal; C J Drake; P Fleming; A Remaley; H B Brewer; W S Argraves
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

6.  Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.

Authors:  X Jiang; O L Francone; C Bruce; R Milne; J Mar; A Walsh; J L Breslow; A R Tall
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

Review 7.  APOA1: a Protein with Multiple Therapeutic Functions.

Authors:  Blake J Cochran; Kwok-Leung Ong; Bikash Manandhar; Kerry-Anne Rye
Journal:  Curr Atheroscler Rep       Date:  2021-02-16       Impact factor: 5.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.